This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Sayantani Roy: Innovator in Cancer Therapeutics
Introduction
Sayantani Roy is a prominent inventor based in Hyderabad, Telangana, India. She has made significant contributions to the field of cancer therapeutics through her innovative research and development. Her work focuses on the selective delivery of genes to cancer cells, which has the potential to revolutionize cancer treatment.
Latest Patents
Sayantani Roy holds a patent for a formulation titled "Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells." This invention utilizes glycolipids and phospholipids isolated from rice bran gum samples in conjunction with gene-carrying lipids. The formulation has shown efficacy in delivering genes selectively to cancer cells while minimizing the delivery to non-cancerous cells. This characteristic highlights its potential use in delivering anticancer therapeutics without causing toxicity to normal cells. She has 1 patent to her name.
Career Highlights
Sayantani Roy is associated with the Council of Scientific and Industrial Research, where she continues her research in innovative therapeutic solutions. Her work is characterized by a commitment to advancing cancer treatment methodologies through scientific exploration and innovation.
Collaborations
Some of her notable coworkers include Rajkumar Banerjee and Pradosh Prasad Chakrabarti, who contribute to her research endeavors and collaborative projects.
Conclusion
Sayantani Roy's innovative work in cancer therapeutics exemplifies the impact of scientific research on healthcare. Her patented formulation represents a significant step forward in the targeted treatment of cancer, showcasing her dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
